Bloomberg
J&J Preps Experimental Ebola Vaccine for May Trial
Oct. 22 -- Bloomberg's Scarlet Fu reports on today's top news stories on Bloomberg Surveillance.
Bloomberg
Will Anything Stop Pfizer's Inversion Plans?
Sept. 23 -- WBB Securities President Stephen Brozak and Bloomberg's Jeffrey McCracken discuss tax inversion deals in the pharmaceutical industry with Pimm Fox on ""Taking Stock."" (Source: Bloomberg)
Bloomberg
Drugmakers Rise on Ebola Treatment Hopes
Oct. 2 -- Scarlet Fu reports on the impact of Ebola on drugmakers stock performance. She speaks on In The Loop. (Source: Bloomberg)
Bloomberg
How Big Pharma Uses Charity Programs to Cover Price Hikes
May 23 -- Bloomberg Businessweek's Ben Elgin explains how patient-assistance funds operate. While they cover much or all of the out-of-pocket drug costs for some of the 40 million Americans receiving Medicare, they also give drug...
Bloomberg
The First All-Female Ferrari Rally in the U.S.
Aug. 10 -- Bloomberg's Hannah Elliott reports on the first U.S. all-female Ferrari rally. She speaks on "Bloomberg Markets."
Bloomberg
The Numbers Don't Lie: What Not to Miss in J&J's Earnings
Jan.23 -- On "The Number's Don't Lie," Scarlet Fu looks at Johnson & Johnson ahead of earnings. She speaks on "What'd You Miss?"
Bloomberg
Bob Doll: Trump Adds to Corrective Noise in Health Stocks
Jan.12 -- Bob Doll, chief equity strategist at Nuveen Asset Management, discusses concern around health care stocks and why he's a buyer of biotech on weakness. He speaks on "Bloomberg Daybreak: Americas."
Bloomberg
Novartis' CEO Says Getting Momentum Back in Alcon Unit
Jul.18 -- Joe Jimenez, chief executive officer at Novartis, discusses second-quarter earnings, the revival at its Alcon eye-care division, the possible IPO for the Alcon unit, their joint venture with Glaxo and drug pricing in the U.S....
Bloomberg
Roche CEO Sees Good Demand for New Medicines
Sep.13 -- Severin Schwan, chief executive officer at Roche, discusses the company’s acquisition strategy, preparations for Brexit, and the potential impact of a trade war. He speaks with Bloomberg's Nejra Cehic on "Bloomberg Surveillance."
Bloomberg
U.S.-Japan Trade Deal Will Take Time to Negotiate, Says AmCham Japan’s Lafleur
Jun.11 -- Christopher Lafleur, chairman at AmCham Japan, discusses U.S.-Japan trade talks, his concerns for the negotiations and his outlook for Japan’s economy. He speaks on “Bloomberg Daybreak: Asia.”
Bloomberg
Breaking Down the Biggest Pharmaceutical Deal on Record
Jan.03 -- Bristol-Myers Squibb Co.’s $74 billion acquisition of drugmaker Celgene Corp. is the biggest deal ever announced this early in a calendar year, according to data compiled by Bloomberg going back to 1990. Bloomberg's Nabila...
Bloomberg
Stick With China’s Largest Pharma Guys, Says Citigroup’s Yung
Jul.23 -- John Yung, head of Asia healthcare research at Citigroup, discusses China’s healthcare sector, the possibility of an expansion to the drug procurement program, consolidation and his outlook for the industry. He speaks on...
Bloomberg
China’s Race for First Covid-19 Vaccine Raises Safety Questions
Nov.02 -- China’s drug makers are racing to leapfrog other pharma firms in developing a coronavirus vaccine. But that speed is raising questions about how stringently they’re vetting and reporting potential safety issues. Bloomberg’s...
Bloomberg
Astra Aims to Bring Vaccine to Many at a Low Cost: CEO
Jul.30 -- AstraZeneca Chief Executive Officer Pascal Soriot discusses the company’s work on a potential coronavirus vaccine and says there has been no evidence of hacking of their vaccine research. He speaks on "Bloomberg Markets:...
Bloomberg
Assessing the Challenges India Faces Amid Covid-19 Outbreak
May.18 -- Pashupati Advani, president of money-management firm Advani Group, talks about the Indian government's efforts to fight the coronavirus outbreak, how the pandemic is affecting his business, and the outlook for the economy and...
Bloomberg
Actavis Tops Valeant Bid to Acquire Allergan in $66B Deal
Nov. 17 -- On Before The Bell, Bloomberg's Betty Liu, Matt Miller, and Julie Hyman run down the top stories of the day. They speak on In The Loop.
Bloomberg
Actavis Draws Nearer to $64B Allergan Acquisition
Nov. 17 -- Bloomberg's Betty Liu reports on today's top news stories on In The Loop.
Bloomberg
Ebola Patient Dies in Nebraska
Nov. 17 -- Bloomberg's Betty Liu reports on today's ""Top Headlines."" She speaks on Bloomberg Television's ""In The Loop. (Source: Bloomberg)
Bloomberg
AbbVie Reconsiders $51.1B Shire Deal on Tax Deal
Oct. 15 -- Bloomberg's Matthew Campbell examines the potential breakdown of a deal between AbbVie and Shire as tax rule changes make the agreement less attractive. He speaks on The Pulse.
Bloomberg
Ackman: Herbalife Execs Talk Pyramid Scheme in Video
Dec. 17 -- Bill Ackman, chief executive officer at Pershing Square, discusses new internal video hes obtained to back up his allegations that Herbalife is a pyramid scheme two years after his short call on the company. He speaks on...
Bloomberg
Have We Seen the End of the Line for Tax Inversion Deals?
April 5 -- Brian Belski, chief investment strategist at BMO, discusses the next phase in tax inversion deals and his outlook for the pharmaceutical industry. He speaks on "Bloomberg Surveillance."
Bloomberg
The Top Three Stocks to Watch in Asia Today
April 13 -- In today's "Stock Exchange," Bloomberg's Yvonne Man, David Ingles and Rosalind Chin discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Valeant Pharma to Restate Earnings After Board Review
Feb. 23 -- Valeant Pharmaceuticals has announced it will restate some past earnings after the company's board looked into the drugmaker's relationship with mail-order pharmacy Philidor Rx Services. Bloomberg's Drew Armstrong reports on...